229 related articles for article (PubMed ID: 18708667)
1. SARS coronavirus and apoptosis.
Chow KY; Yeung YS; Hon CC; Zeng F; Law KM; Leung FC
Hong Kong Med J; 2008 Aug; 14 Suppl 4():8-13. PubMed ID: 18708667
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated expression of the C-terminal domain of SARS-CoV spike protein is sufficient to induce apoptosis in Vero E6 cells.
Chow KY; Yeung YS; Hon CC; Zeng F; Law KM; Leung FC
FEBS Lett; 2005 Dec; 579(30):6699-704. PubMed ID: 16310778
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats.
Liu RY; Wu LZ; Huang BJ; Huang JL; Zhang YL; Ke ML; Wang JM; Tan WP; Zhang RH; Chen HK; Zeng YX; Huang W
Virus Res; 2005 Sep; 112(1-2):24-31. PubMed ID: 16022898
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional profiling of Vero E6 cells over-expressing SARS-CoV S2 subunit: insights on viral regulation of apoptosis and proliferation.
Yeung YS; Yip CW; Hon CC; Chow KY; Ma IC; Zeng F; Leung FC
Virology; 2008 Feb; 371(1):32-43. PubMed ID: 17961624
[TBL] [Abstract][Full Text] [Related]
5. Receptor-binding domain of SARS-Cov spike protein: soluble expression in E. coli, purification and functional characterization.
Chen J; Miao L; Li JM; Li YY; Zhu QY; Zhou CL; Fang HQ; Chen HP
World J Gastroenterol; 2005 Oct; 11(39):6159-64. PubMed ID: 16273643
[TBL] [Abstract][Full Text] [Related]
6. The spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells.
Wu XD; Shang B; Yang RF; Yu H; Ma ZH; Shen X; Ji YY; Lin Y; Wu YD; Lin GM; Tian L; Gan XQ; Yang S; Jiang WH; Dai EH; Wang XY; Jiang HL; Xie YH; Zhu XL; Pei G; Li L; Wu JR; Sun B
Cell Res; 2004 Oct; 14(5):400-6. PubMed ID: 15450134
[TBL] [Abstract][Full Text] [Related]
7. Expression and functional characterisation of the putative SARS coronavirus non-structural proteins X1-X5.
Ho YY
Hong Kong Med J; 2008 Aug; 14 Suppl 4():4-7. PubMed ID: 18708666
[TBL] [Abstract][Full Text] [Related]
8. Molecular and genetic characterisation of the SARS coronavirus auxiliary protein X1 in Drosophila.
Chan E; Tsui S; Chan CM; Chan CS; Chen YW; Law P; Wong A
Hong Kong Med J; 2008 Aug; 14 Suppl 4():14-6. PubMed ID: 18708668
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion.
Petit CM; Melancon JM; Chouljenko VN; Colgrove R; Farzan M; Knipe DM; Kousoulas KG
Virology; 2005 Oct; 341(2):215-30. PubMed ID: 16099010
[TBL] [Abstract][Full Text] [Related]
10. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
[TBL] [Abstract][Full Text] [Related]
11. Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein.
Giroglou T; Cinatl J; Rabenau H; Drosten C; Schwalbe H; Doerr HW; von Laer D
J Virol; 2004 Sep; 78(17):9007-15. PubMed ID: 15308697
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of SARS-CoV replication by siRNA.
Wu CJ; Huang HW; Liu CY; Hong CF; Chan YL
Antiviral Res; 2005 Jan; 65(1):45-8. PubMed ID: 15652970
[TBL] [Abstract][Full Text] [Related]
13. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice.
Becker MM; Graham RL; Donaldson EF; Rockx B; Sims AC; Sheahan T; Pickles RJ; Corti D; Johnston RE; Baric RS; Denison MR
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19944-9. PubMed ID: 19036930
[TBL] [Abstract][Full Text] [Related]
14. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
Bosch BJ; Martina BE; Van Der Zee R; Lepault J; Haijema BJ; Versluis C; Heck AJ; De Groot R; Osterhaus AD; Rottier PJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8455-60. PubMed ID: 15150417
[TBL] [Abstract][Full Text] [Related]
15. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV.
Fukushi S; Mizutani T; Saijo M; Kurane I; Taguchi F; Tashiro M; Morikawa S
J Med Virol; 2006 Dec; 78(12):1509-12. PubMed ID: 17063504
[TBL] [Abstract][Full Text] [Related]
17. Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain.
Belouzard S; Madu I; Whittaker GR
J Biol Chem; 2010 Jul; 285(30):22758-63. PubMed ID: 20507992
[TBL] [Abstract][Full Text] [Related]
18. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.
Ho TY; Wu SL; Chen JC; Wei YC; Cheng SE; Chang YH; Liu HJ; Hsiang CY
Antiviral Res; 2006 Feb; 69(2):70-6. PubMed ID: 16337697
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
Li W; Moore MJ; Vasilieva N; Sui J; Wong SK; Berne MA; Somasundaran M; Sullivan JL; Luzuriaga K; Greenough TC; Choe H; Farzan M
Nature; 2003 Nov; 426(6965):450-4. PubMed ID: 14647384
[TBL] [Abstract][Full Text] [Related]
20. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles.
Siu YL; Teoh KT; Lo J; Chan CM; Kien F; Escriou N; Tsao SW; Nicholls JM; Altmeyer R; Peiris JS; Bruzzone R; Nal B
J Virol; 2008 Nov; 82(22):11318-30. PubMed ID: 18753196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
